About Pacific Biosciences of California (PACB)

The current price per share for Pacific Biosciences of California (PACB) is $1.85. The stock has seen a price change of $0.05 recently, indicating a 2.78% change. This reflects the stock's recent market performance and investor sentiment.

For Pacific Biosciences of California (PACB), the 52-week high is $10.65, which is 475.68% from the current price. The 52-week low is $1.16, the current price is 59.48% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

Pacific Biosciences of California (PACB) has shown an average price growth of -3.36% over the past three years. It has received a score of 4 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Pacific Biosciences of California as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

As of the latest data, Pacific Biosciences of California (PACB) has a year-to-date price change of -80.71%. Over the past month, the stock has experienced a price change of 7.56%. Over the last three months, the change has been 15.62%. Over the past six months, the figure is -1.07%. Looking at a longer horizon, the five-year price change stands at -63.8%.

Pacific Biosciences of California (PACB) has a net income of -$306.74M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 26.32% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -140.13% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $200.52M, with a revenue growth rate of 56.29%, providing insight into the company's sales performance and growth. The gross profit is $52.78M. Operating income is noted at -$334.47M. Furthermore, the EBITDA is -$242.92M.

Pacific Biosciences of California (PACB) has a market capitalization of $506.65M. The average daily trading volume is 1.89, indicating the stock's liquidity and investor engagement.